Stein Sundstrøm

4.0k citations

78 papers · 2.6k indexed · h-index 26

Impact in

Oncology top 2%
- Lung Cancer Research Studies
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

Otorhinolaryngology 7
- Head and Neck Cancer Studies 7
Pulmonary and Respiratory Medicine 50
- Lung Cancer Treatments and Mutations 32
- Lung Cancer Diagnosis and Treatment 19
- Occupational and environmental lung diseases 13
- Pleural and Pulmonary Diseases 8

Co-authors: Roy M. Bremnes Ulf Aasebø Stein Kaasa Steinar Aamdal Paal Brunsvig Reidulv Hatlevoll Jan Vilsvik Christian von Plessen
Journals: Journal of Clinical Oncology (13 papers)Lung Cancer (12 papers)Journal of Thoracic Oncology (9 papers)European Journal of Cancer (6 papers)Acta Oncologica (5 papers)
Partner nations: Norway Sweden Denmark

In The Last Decade

Stein Sundstrøm

78 papers receiving 2.5k citations

Peers

Countries citing papers authored by Stein Sundstrøm

Since Specialization

Citations

This map shows the geographic impact of Stein Sundstrøm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stein Sundstrøm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stein Sundstrøm more than expected).

Fields of papers citing papers by Stein Sundstrøm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stein Sundstrøm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stein Sundstrøm. The network helps show where Stein Sundstrøm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stein Sundstrøm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stein Sundstrøm Line = papers co-authored together Stein Sundstrøm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer Lung Cancer ·Tarje Onsøien Halvorsen, Fabian Aleksic, Nina Jackson Levin, Roy M. Bremnes, Odd Terje Brustugun, Øystein Fløtten, Stein Kaasa, Stein Sundstrøm, Bjørn Henning Grønberg	2016	11
2	How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial Clinical Lung Cancer ·Shuman Gao, Roy M. Bremnes, Stein Sundstrøm, Hugh R. Montgomery, Ulf Aasebø	2014	14
3	Arbeidsbetinget lungekreft i Sør-Trøndelag Tidsskrift for Den norske legeforening ·Monica Skatrud-Mickelson, Chen Shao-lian, V K Kapur, Tore Amundsen, Sveinung Sørhaug, Stein Sundstrøm, Bjørn Henning Grønberg, Bjørn Hilt	2014	3
4	Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma PLoS ONE ·Oluf Dimitri Røe, J Malfanti, Endre Anderssen, Arnar Flatberg, Johannes E. Jäntti, Tore Amundsen, 廖　霄, Katalin Dobra, Stein Sundstrøm	2012	33
5	Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial Clinical Cancer Research ·Paal Brunsvig, Jon Amund Kyte, Christian Kersten, Stein Sundstrøm, Mona Møller, Marta Nyakas, Ююкин Максим Анатольевич, Gustav Gaudernack, Steinar Aamdal	2011	131
6	Astroblastoma – a case report of a rare neuroepithelial tumor with complete remission after chemotherapy Clinical Neuropathology ·Angela Yoo, Stein Sundstrøm, Sasha Gulati, Sverre H. Torp	2011	12
7	Potentially Curative Radiotherapy for Non–Small-Cell Lung Cancer in Norway: A Population-Based Study of Survival International Journal of Radiation OncologyBiologyPhysics ·Trond‐Eirik Strand, Zhu Qiming, Dag Clement Johannessen, Stein Sundstrøm, Yong Man Park, Kjersti Hornslien, Roy M. Bremnes, Andreas Stensvold, Hector Politt, Jarle Norstein	2010	10
8	Chemotherapy and quality of life in NSCLC PS 2 patients Acta Oncologica ·Hugh R. Montgomery, Shuman Gao, Stein Sundstrøm, Ulf Aasebø, Christian von Plessen, Roy M. Bremnes, (unknown)	2009	11
9	Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up Journal of the European Academy of Dermatology and Venereology ·Eidi Christensen, Eirik Skogvoll, Trond Viset, Trond Warloe, Stein Sundstrøm	2008	40
10	Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study Journal of Thoracic Oncology ·Gunnar Hillerdal, Jens Benn Sørensen, Stein Sundstrøm, Henrik Riska, Anders Vikström, Anders Hjerpe	2008	35
11	Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study The Clinical Respiratory Journal ·Gunnar Hillerdal, Jens Benn Sørensen, Stein Sundstrøm, Anders Vikström, Anders Hjerpe	2008	7
12	Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy Lung Cancer ·Hugh R. Montgomery, Ulf Aasebø, Stein Sundstrøm, Christian von Plessen, Paal Brunsvig, Roy M. Bremnes	2008	12
13	A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer Lung Cancer ·Bjørn Henning Grønberg, Roy M. Bremnes, Ulf Aasebø, Paal Brunsvig, Øystein Fløtten, Tore Amundsen, Christian von Plessen, Yong Man Park, Stein Sundstrøm	2008	26
14	Pemetrexed plus cisplatin (P plus CIS) or carboplatin (P plus CB) in chemonaive malignant pleural mesothelioma (MPM) patients (PTS): Results of the international expanded access program (EAP) Annals of Oncology ·Armando Santoro, Paolo Andrea Zucali, Mary O’Brien, Rolf A. Stahel, Kristiaan Nackaerts, Paul Baas, L. Paz-Ares, Stein Sundstrøm, J. Blatter, C. Manegold	2007	1
15	C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP) Journal of Thoracic Oncology ·Christian Manegold, Armando Santoro, Mary O’Brien, Rolf A. Stahel, Kristiaan Nackaerts, Paul Bass, Luis Paz‐Ares, Stein Sundstrøm, Carla Visseren‐Grul, J. Blatter	2007	2
16	Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment Journal of Thoracic Oncology ·Jens Benn Sørensen, Stein Sundstrøm, Erna Neunteufel, Erich Schachl	2007	42
17	Anal carcinoma in mid-Norway 1970–2000 Acta Oncologica ·清一小笠原, Arne Wibe, Stein Sundstrøm, Rune Haaverstad, Stein Kaasa, H. E. Myrvold	2007	5
18	Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity British Journal of Cancer ·(unknown), Hugh R. Montgomery, Stein Sundstrøm, Ulf Aasebø, Paal Brunsvig, Christian von Plessen, Harald Hjelde, Hector Politt, Liu Congfen, Roy M. Bremnes	2007	60
19	Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer British Journal of Cancer ·(unknown), Christian von Plessen, Bengt Bergman, Aditya Wibawa, R. M. Bremnes, Stein Sundstrøm, Widemon Reginald, RJ Stephens, Jan Vilsvik, Ulf Aasebø, S Sörenson	2006	124
20	Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study Radiotherapy and Oncology ·Stein Sundstrøm, Roy M. Bremnes, Paal Brunsvig, Ulf Aasebø, Olbjørn Klepp, Peter Fayers, Stein Kaasa	2005	23

About Stein Sundstrøm

Stein Sundstrøm is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Genetics, having authored 78 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (28 papers), Lung Cancer Diagnosis and Treatment (19 papers), Neuroendocrine Tumor Research Advances (17 papers), Occupational and environmental lung diseases (13 papers), Cancer therapeutics and mechanisms (9 papers), Pleural and Pulmonary Diseases (8 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.3k citations), Epidemiology (791 citations), Otorhinolaryngology (87 citations) and Geriatrics and Gerontology (47 citations). Stein Sundstrøm has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Roy M. Bremnes, Ulf Aasebø, Stein Kaasa, Steinar Aamdal, Paal Brunsvig, Reidulv Hatlevoll, Jan Vilsvik, Christian von Plessen, Bjørn Henning Grønberg and Øystein Fløtten. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology, European Journal of Cancer and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact